Inventor · disambiguated record
Phillip David Monk
Also filed as: MONK PHILLIP · MONK PHILLIP DAVID
7 granted patents·4 pending applications·44 citations·filing 2004–2021
85Inventor score
Top patents by PatentIndex Score
11 records- 0188US7947273B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2007·Granted May 24, 2011·10 cites·18 claims
- 0284US7935343B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2004·Granted May 3, 2011·14 cites·45 claims
- 0383US7959917B2Binding members for IgE moleculesMEDIMMUNE LTD·Filed 2008·Granted Jun 14, 2011·6 cites·13 claims
- 0481US9856317B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 0580US7829090B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2004·Granted Nov 9, 2010·9 cites·22 claims
- 0671US9315575B2Methods of treatment using human antibody molecules for IL-13MONK PHILLIP DAVID·Filed 2010·Granted Apr 19, 2016·2 cites·72 claims
- 0762US2018230209A1Human antibody molecules for il-13MEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 0854US2023338475A1USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTSSYNAIRGEN RES LIMITED·Filed 2021·Application pending·0 cites
- 0953US2014127212A1Binding Members For IgE MoleculesMEDIMMUNE LTD·Filed 2012·Application pending·0 cites
- 1050US9421243B2Therapy for influenza like illnessTEAR VICTORIA JANE·Filed 2011·Granted Aug 23, 2016·1 cites·5 claims
- 1147US2023241177A1Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroidSYNAIRGEN RES LIMITED·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →